Kenny Lim
Nov 26, 2008

Bates141 bags Merck business in Indonesia

JAKARTA - Global pharmaceutical firm Merck has appointed Bates141 for its estimated US$2 million creative business in Indonesia to develop communications for its portfolio of products in 2009.

Bates141 bags Merck business in Indonesia
The WPP firm bagged the account following strategy and creative presentations and has been tasked with repositioning vitamin supplements including Neurobion and Sangobion, which are popular over the counter brands, to a wider audience in Indonesia.

Other products in Bates’s remit include Becombion and Seven Seas. Merck had previously worked with DDB.

There are currently 29 international pharmaceutical companies marketing their products in Indonesia’s $2 billion pharmaceutical industry. Indonesian authorities have also recently imposed a ruling that requires foreign drug companies to establish local production facilities.

Related Articles

Just Published

1 day ago

Creative Minds: 'Go smash it like an avocado' is ...

She once dreamed of covering war zones, not crafting ad campaigns. But a surprising turn of events led this TBWA Australia creative director to a career where "smashing it like an avocado" became her unexpected motto.

1 day ago

Price-gouging in Aussie supermarkets: Where does ...

As supermarket price wars heat up, Woolworths and Coles are losing ground to Aldi, according to data from YouGov.

1 day ago

Gen AI will have a profound impact on agency ...

With clients increasingly handling business-as-usual tasks in-house, agency profitability is at risk unless agencies redefine the value of their creative services, says brand and marketing consultant Andreas Moellmann.

1 day ago

Call for submissions: Do you want to be featured in ...

Campaign's weekly, fun-filled interview series with APAC creatives is now open for entries. No deadlines, just pure creativity. Get the details here.